The National Health Surveillance Directorate (Dinavisa) has issued a strong warning to the public about the illegal sale of products claiming to contain tirzepatide, an active ingredient used for weight control and diabetes. The sale occurs via the internet, digital platforms, and social media, without any health registration or quality control.
According to the official statement, the products identified in the informal market have no origin supervised by regulatory bodies, which represents a critical health risk. Dinavisa advises the public not to purchase or use these items, as they may contain incorrect doses, toxic substances, or microbiological contamination.
Self-medication and purchasing medicines on the black market put patients' lives at risk. Before acquiring any treatment, it is essential to verify that the product has Dinavisa's health registration visible on the packaging.
To report the illegal sale or counterfeiting of these or other medicines, the institution provides reporting channels on its official website.